A Study of HIV in Newly Infected Individuals
Public ClinicalTrials.gov record NCT00000930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Infected Participants Protocol: Evaluation of Natural History of HIV Infection in Newly HIV-Infected Persons in HIVNET Target Populations
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see how HIV reacts in the immune systems of patients who have recently been infected with HIV. This study also examines HIV's resistance to anti-HIV drugs in newly infected patients. Certain populations are good candidates for participation in HIV vaccine trials. These groups include men who have sex with men, IV drug users, and women at risk of getting HIV through heterosexual contact. Learning how HIV behaves in these populations once they become infected can help with the planning of future HIV vaccine studies.
Study identification
- NCT ID
- NCT00000930
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- May 2008 (Actual)
- Completion
- May 2008 (Actual)
- Last update posted
- Nov 7, 2016
Ends 2008
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Los Angeles County / Health Research Assoc / Drew Med Ctr | Los Angeles | California | 90033 | — |
| San Francisco Dept of Hlth / AIDS Office | San Francisco | California | 94102 | — |
| Denver Dept of Public Health / HIVNET | Denver | Colorado | 80204 | — |
| Univ of Illinois Chicago / Howard Brown Hlth Ctr | Chicago | Illinois | 60612 | — |
| Johns Hopkins Univ | Baltimore | Maryland | 21205 | — |
| Fenway Community Health Ctr / HIVNET | Boston | Massachusetts | 02115 | — |
| New York Univ Med Ctr | New York | New York | 10016 | — |
| Bronx-Lebanon Hosp Ctr | The Bronx | New York | 10453 | — |
| New York Blood Ctr | The Bronx | New York | 10456 | — |
| Univ of Pennsylvania / HIVNET | Philadelphia | Pennsylvania | 19104 | — |
| Miriam Hosp | Providence | Rhode Island | 02906 | — |
| Univ of Washington | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00000930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2016 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00000930 live on ClinicalTrials.gov.